These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14757158)

  • 21. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
    Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
    Andersen HS; Olsen OH; Iversen LF; Sørensen AL; Mortensen SB; Christensen MS; Branner S; Hansen TK; Lau JF; Jeppesen L; Moran EJ; Su J; Bakir F; Judge L; Shahbaz M; Collins T; Vo T; Newman MJ; Ripka WC; Møller NP
    J Med Chem; 2002 Sep; 45(20):4443-59. PubMed ID: 12238924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity.
    Nguyen PH; Yang JL; Uddin MN; Park SL; Lim SI; Jung DW; Williams DR; Oh WK
    J Nat Prod; 2013 Nov; 76(11):2080-7. PubMed ID: 24224843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity.
    Pei Z; Liu G; Lubben TH; Szczepankiewicz BG
    Curr Pharm Des; 2004; 10(28):3481-504. PubMed ID: 15579047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.
    Cho SY; Baek JY; Han SS; Kang SK; Ha JD; Ahn JH; Lee JD; Kim KR; Cheon HG; Rhee SD; Yang SD; Yon GH; Pak CS; Choi JK
    Bioorg Med Chem Lett; 2006 Feb; 16(3):499-502. PubMed ID: 16289879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors.
    Lau CK; Bayly CI; Gauthier JY; Li CS; Therien M; Asante-Appiah E; Cromlish W; Boie Y; Forghani F; Desmarais S; Wang Q; Skorey K; Waddleton D; Payette P; Ramachandran C; Kennedy BP; Scapin G
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1043-8. PubMed ID: 15013020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein tyrosine phosphatase-1B in diabetes.
    Kennedy BP; Ramachandran C
    Biochem Pharmacol; 2000 Oct; 60(7):877-83. PubMed ID: 10974195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation.
    Bustanji Y; Taha MO; Yousef AM; Al-Bakri AG
    J Enzyme Inhib Med Chem; 2006 Apr; 21(2):163-71. PubMed ID: 16789430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phloridzin Acts as an Inhibitor of Protein-Tyrosine Phosphatase MEG2 Relevant to Insulin Resistance.
    Yoon SY; Yu JS; Hwang JY; So HM; Seo SO; Kim JK; Jang TS; Chung SJ; Kim KH
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
    Hooft van Huijsduijnen R; Sauer WH; Bombrun A; Swinnen D
    J Med Chem; 2004 Aug; 47(17):4142-6. PubMed ID: 15293983
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B.
    Doman TN; McGovern SL; Witherbee BJ; Kasten TP; Kurumbail R; Stallings WC; Connolly DT; Shoichet BK
    J Med Chem; 2002 May; 45(11):2213-21. PubMed ID: 12014959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro protein tyrosine phosphatase 1B inhibitory phenols from the seeds of Psoralea corylifolia.
    Kim YC; Oh H; Kim BS; Kang TH; Ko EK; Han YM; Kim BY; Ahn JS
    Planta Med; 2005 Jan; 71(1):87-9. PubMed ID: 15678382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance].
    Boduła A; Wdowczyk M; Adamiec R
    Postepy Hig Med Dosw (Online); 2005 May; 59():203-7. PubMed ID: 15928604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting protein tyrosine phosphatases for anticancer drug discovery.
    Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
    Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism for differential effect of protein-tyrosine phosphatase 1B on Akt versus mitogen-activated protein kinase in 3T3-L1 adipocytes.
    Shimizu S; Maegawa H; Egawa K; Shi K; Bryer-Ash M; Kashiwagi A
    Endocrinology; 2002 Dec; 143(12):4563-9. PubMed ID: 12446583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel series of (S)-2,7-substituted-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor α/γ dual agonists with protein-tyrosine phosphatase 1B inhibitory activity.
    Otake K; Azukizawa S; Fukui M; Shibabayashi M; Kamemoto H; Miike T; Kunishiro K; Kasai M; Shirahase H
    Chem Pharm Bull (Tokyo); 2011; 59(10):1233-42. PubMed ID: 21963632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.